KMKaichi Ma

Kaichi Ma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kaichi Ma has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Han Lin

    Department of Gynecology of Traditional Chinese Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    1 shared publication
  • Miaoxian Ou

    Center for Reproductive Medicine, Department of Obstetrics and Gynecology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    1 shared publication
  • Mingxing Liu

    Department of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    1 shared publication
  • Pei Xu

    Department of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional Study

    by Miaoxian Ou, Pei Xu, Han Lin, Kaichi Ma, Mingxing Liu

    Objective. The relationship between metabolic risk and ovarian function is ambiguous. This retrospective study analyzed the medical records of 461 PCOS patients collected between January 2019 and June 2020 to investigate the relationship between serum anti-Müllerian hormone (AMH) and parameters of metabolic risk in the population with polycystic ovary syndrome (PCOS). Methods. A total of 461 PCOS patients aged 2040 years were included and stratified into four groups according to the AMH level. The association between AMH and the parameters related to metabolic risk in these groups was compared, and the discrepancies were further explored. Binary logistic regression was performed to examine the risk factors of HOMA-IR. The values of AMH that best predicted the risk of HOMA-IR were also analyzed by ROC curves. Results. AMH was negatively associated with HOMA-IR (odds ratio (OR) 0.279, 95 confidence interval (CI) 0.36 to 0.20), fasting insulin (OR 0.282, 95 CI 0.36 to 0.20), 1-hour postprandial insulin (OR 0.184, 95 CI 0.28 to 0.11), 2-hour postprandial insulin (0.180, 95CI 0.28 to 0.11), 3-hour postprandial insulin (OR 0.198, 95 CI 0.30 to 0.13), waist-hip ratio (OR 0.235, 95 CI 0.31 to 0.14), and body mass index (OR 0.350, 95 CI 0.43 to 0.27). There was no statistically significant relationship between blood pressure, serum glucose profile, or lipid levels and AMH. Binary logistic regression showed that AMH protected against the occurrence of PCOS patients (OR: 0.835, 0.776, and 0.898). For the prediction of HOMA-IR, AMH had an AUC-ROC of 0.704 (95 CI 0.6520.755) with a cutoff value of 7.81mmol/L, a sensitivity of 70.3, and a specificity of 70.1. Conclusions. Higher AMH levels were significantly associated with a lower insulin profile and might be a useful predictor for HOMA-IR in PCOS patients.